HIGHLIGHTS
- who: Matthias Hettchen and collaborators from the The present study was conducted between January , and January , as a randomized controlled, semi-blinded trial (RCT) with a parallel group designThe Institute of Medical Physics (IMP), University of Erlangen-Nu00fcrnberg (FAU), Germany planned, implemented and realized the study. The RCT was approved by the Ethics Committee (number, b) and data protection agency of the FAU. The study fully complies with the Helsinki Declaration (25) and was fully registered under ClinicalTrials.gov: NCT04854629. All the study participants gave their written informed consent after detailed information. Figure , shows the timeline of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.